RETRACTED ARTICLE: Ras-ERK1/2 signalling promotes the development of osteosarcoma through regulation of H4K12ac through HAT1

Abstract

We, the Editors and Publisher of the journal Artificial Cells, Nanomedicine, and Biotechnology, have retracted the following article:

Jingzhe Zhang, Meihan Liu, Wanguo Liu & Wenjun Wang (2019) Ras-ERK1/2 signalling promotes the development of osteosarcoma through regulation of H4K12ac through HAT1, Artificial Cells, Nanomedicine, and Biotechnology, 47:1, 1207–1215, DOI: 10.1080/21691401.2019.1593857

Since publication, concerns have been raised about the integrity of the data in the article. When approached for an explanation, the authors checked their data and confirmed there are fundamental errors present. Therefore, they have agreed to the retraction of this article. The authors apologise for this oversight.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.

View retraction statement:

Statement of Retraction

View addendum:

Expression of concern: Ras-ERK1/2 signalling promotes the development of osteosarcoma through regulation of H4K12ac through HAT1